Fasenra Pen
Generic name: Benralizumab
Drug class:
Interleukin inhibitors
Usage of Fasenra Pen
Fasenra Pen is a monoclonal antibody that affects the actions of the body's immune system. This medicine works by reducing levels of eosinophils, a certain type of white blood cell that may contribute to the symptoms of asthma.
Fasenra Pen is used together with other medicines to help control severe asthma in adults and children who are at least 12 years old. This medicine is for people whose asthma is not well controlled with other medications.
Fasenra Pen may also be used for purposes not listed in this medication guide.
Fasenra Pen side effects
Get emergency medical help if you have signs of an allergic Reaction: hives, rash; difficult breathing, feeling light-headed; swelling of your face, lips, tongue, or throat.
Fasenra Pen may cause serious side effects. Call your doctor at once if you have:
Common side effects of Fasenra Pen may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Fasenra Pen
You should not be treated with Fasenra Pen if you are allergic to it.
Tell your doctor if you have ever had:
Follow your doctor's instructions about receiving Fasenra Pen if you are pregnant. Not treating asthma during pregnancy could harm both mother and baby. Tell your doctor if you are pregnant or plan to become pregnant.
It may not be safe to breast-feed a baby while you are using this medicine. Ask your doctor about any risks.
Fasenra Pen should not be given to a child younger than 12 years old.
Relate drugs
- Actemra
- Actemra ACTPen
- Adbry
- Arcalyst
- Cosentyx
- Basiliximab
- Benralizumab
- Brodalumab
- Canakinumab
- Cinqair
- Daclizumab
- Dupilumab
- Dupixent
- Dupixent Pre-filled Pen
- Dupixent Pre-filled Syringe
- Enspryng
- Fasenra
- Fasenra Pen
- Fasenra Prefilled Syringe
- Guselkumab
- Ilaris
- Ilumya
- Ixekizumab
- Mepolizumab
- Nucala
- Reslizumab
- Rilonacept
- Risankizumab
- Risankizumab-rzaa
- Satralizumab
- Satralizumab-mwge
- secukinumab
- Siliq
- Siltuximab
- Simulect
- Skyrizi
- Skyrizi Pen
- Spesolimab
- Spesolimab-sbzo
- Spevigo
- Stelara
- Sylvant
- Taltz
- Tildrakizumab
- Tildrakizumab-asmn
- Tocilizumab
- Tralokinumab
- Tralokinumab-ldrm
- Tremfya
- Ustekinumab
- Zinbryta
How to use Fasenra Pen
Before you start treatment with Fasenra Pen, your doctor may perform tests to measure your eosinophil levels.
Fasenra Pen is injected under the skin. A healthcare provider will give you this injection, usually once every 4 weeks at first and then once every 8 weeks.
Follow your doctor's dosing instructions very carefully.
If you've been using a steroid medication, do not stop using it unless your doctor tells you to.
Fasenra Pen is not a rescue medicine for asthma attacks. Use only fast-acting inhalation medicine for an attack. Seek medical attention if your fast-acting medicine does not work.
You may need frequent medical tests to help your doctor determine how long to treat you with Fasenra Pen.
Asthma is often treated with a combination of drugs. Use all medications as directed and read all medication guides. Do not change your dose or dosing schedule without your doctor's advice. Your dose needs may change due to surgery, illness, stress, or a recent asthma attack. Tell your doctor if any of your medicines seem to stop working.
Warnings
Before you receive Fasenra Pen, tell your doctor about all your medical conditions or allergies, all medicines you use, and if you are pregnant or breast-feeding.
What other drugs will affect Fasenra Pen
Other drugs may affect Fasenra Pen, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions